The Global Market for Gel Documentation Systems (2018-2023): Projected to Exceed $300 Million by 2023 — North America is Expected to Dominate

Dublin, Dec. 10, 2018 (GLOBE NEWSWIRE) -- The "Gel Documentation Systems Market by Product, Light Source, Detection, Application, End User - Global Forecast to 2023" report has been added to's offering.

The gel documentation systems market is projected to reach USD 304.13 million by 2023 from USD 258.56 million in 2018, at a CAGR of 3.3% during the forecast period.

Market growth is largely driven by the growing global incidence of infectious diseases and genetic disorders and growth in funding for research on genomic, proteomic, and electrophoresis techniques.

However, the growing adoption of quantitative polymerase chain reaction (qPCR) is expected to limit market growth to a certain extent in the coming years.

Based on end user, the gel documentation systems market has been segmented into academic and research institutes; pharmaceutical & biotechnology companies; diagnostic laboratories.

The academic and research institutes segment is estimated to account for the largest share of the overall market in 2018. This growth is primarily attributed to the increasing research activities on genomics and proteomics in research institutes and rising government funding in academic institutes.

Based on product, the gel documentation systems market is segmented into three segments, namely, instruments, software, and accessories. The instruments segment is further divided into digital gel documentation instruments and gel documentation instruments.

During the forecast period, the instruments segment is estimated to register the highest growth rate in the overall gel documentation systems market. This growth is mainly due to the increasing research & development activities in the biotechnology and pharmaceutical industries.

Based on region, the gel documentation systems market has been segmented into North America, Europe, Asia Pacific (APAC), and the Rest of the World (RoW).

North America is expected to dominate the global gel documentation systems market in 2018. The large share of North America in this market is attributed to the increasing research in the fields of proteomics and genomics, increasing R&D by pharmaceutical and biotechnology companies, the presence of a highly developed biotechnology research infrastructure, and the availability of government grants to support research.

The major players in the gel documentation systems market are GE Healthcare (US), Bio-Rad Laboratories (US), Thermo Fisher Scientific (US), LI-COR Biosciences (US), Endress+Hauser Management AG (Switzerland), Vilber Lourmat (France), Scientific Digital Imaging plc (UK), Bio-Techne (US), Cleaver Scientific (US), and Azure Biosystems (US).

Key Topics Covered

1. Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Markets Covered
1.2.2 Country Coverage
1.2.3 Years Considered for the Study
1.3 Currency
1.4 Limitations
1.5 Stakeholders

2. Research Methodology
2.1 Secondary Data
2.1.1 Key Data From Secondary Sources
2.2 Primary Data
2.2.1 Key Data From Primary Sources
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Market Breakdown and Data Triangulation
2.5 Assumptions for the Study

3. Executive Summary

4. Premium Insights
4.1 Gel Documentation Systems: Market Overview
4.2 Asia Pacific: Gel Documentation Systems Market, By Product (2018)
4.3 Gel Documentation Systems Market, By Region (2018)
4.4 Gel Documentation Systems Market: Geographic Growth Opportunities

5. Market Overview
5.1 Introduction
5.2 Market Dynamics
5.3 Drivers
5.3.1 Growing Global Incidence of Infectious Diseases and Genetic Disorders
5.3.2 Growth in Funding for Research on Genomic, Proteomic and Electrophoresis Techniques
5.4 Restraints
5.4.1 Growing Adoption of Quantitative Polymerase Chain Reaction (QPCR)
5.5 Opportunities
5.5.1 Technological Advancements in Gel Documentation Systems
5.5.2 Growth Opportunities in Emerging Economies

6. Gel Documentation Systems Market, By Product
6.1 Introduction
6.2 Instruments
6.2.1 Digital Gel Documentation Instruments Digital Gel Documentation Instruments to Witness the Highest Growth During the Forecast Period
6.2.2 Film Gel Documentation Instruments Market for Film Gel Documentation Instruments is Declining
6.3 Software
6.3.1 Software is A Necessary Component in the Functioning of Digital Gel Documentation Systems
6.4 Accessories
6.4.1 Gel Documentation Accessories to Account for A Relatively Smaller Share of the Market

7. Gel Documentation Systems Market, By Light Source
7.1 Introduction
7.2 Light-Emitting Diodes
7.2.1 Energy Efficiency and Low Maintenance & Disposal Costs Associated With Leds to Drive the Growth of This Market
7.3 UV
7.3.1 The Use of Ethidium Bromide has Decreased Due to Its Toxicity
7.4 Laser
7.4.1 Images Produced By Laser Light Sources are More Accurate and Clearer

8. Gel Documentation Systems Market, By Detection Technique
8.1 Introduction
8.2 Ultraviolet
8.2.1 UV Detectors Provide Good Sensitivity for Light-Absorbing Gels
8.3 Chemiluminescence
8.3.1 Technological Limitations Affecting Detection Range Affect Reliance on Chemiluminescence
8.4 Fluorescence
8.4.1 Fluorescence Detection Provides a Broad Linear Dynamic Range, Signal Stability, and Multiplex Detection

9. Gel Documentation Systems Market, By Application
9.1 Introduction
9.2 Nucleic Acid Quantification
9.2.1 Increase in Government and Private Funding for Proteomics and Protein-Based Research to Drive Market Growth
9.3 Protein Quantification
9.3.1 Increasing Government Funding for Genomics and Proteomics Research is a Major Driving Factor
9.4 Other Applications

10. Gel Documentation Systems Market, By End User
10.1 Introduction
10.2 Academic & Research Institutes
10.2.1 Growing Government Initiatives By Governments to Support Genomic and Proteomic Research Projects at the University Level are Expected to Drive Market Growth
10.3 Pharma & Biotech Companies
10.3.1 Pharma and Biotech Companies Use Gel Documentation Systems in Drug Discovery and Development and R&D Processes
10.4 Diagnostic Laboratories
10.4.1 The Demand for Gel Documentation Systems is Increasing in Diagnostic Laboratories Owing to the Growth in the Volume of Patient Samples to Be Tested

11. Gel Documentation Systems Market, By Region
11.1 Introduction
11.2 North America
11.2.1 US Increasing Government Funding for R&D Studies
11.2.2 Canada Growing Investments in Proteomics and Genomics
11.3 Europe
11.3.1 Strong Academic & Research Base and Availability of Research Funding in European Countries
11.4 Asia Pacific
11.4.1 Japan Growing Genomic and Proteomic Studies and Rising Research Investments
11.4.2 China Increasing Government Interest in Biomedical and Biotechnology Industry
11.4.3 India R&D Activity in the Indian Pharmaceutical and Biotechnology Industries Will Grow at a High Rate
11.4.4 RoAPAC
11.5 Rest of the World

12. Competitive Landscape
12.1 Overview
12.2 Market Ranking Analysis, 2017
12.3 Competitive Scenario
12.3.1 Product Launches
12.3.2 Agreements
12.3.3 Expansions
12.3.4 Acquisitions

13. Company Profiles
13.1 Bio-Rad
13.2 GE Healthcare
13.3 Thermo Fisher Scientific
13.4 Li-Cor Biosciences
13.5 Analytic Jena AG (A Subsidiary of Endress + Hauser Management AG)
13.6 Vilber Lourmat
13.7 Syngene
13.8 Bio-Techne
13.9 Cleaver Scientific
13.10 Azure Biosciences Inc.

For more information about this report visit

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

         Laura Wood, Senior Press Manager
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
Related Topics: Laboratory Equipment


You May Also Like

Dynavax to Host Second Quarter 2018 Financial Results Conference Call

Update on HEPLISAV-B® and Timing of Oncology DataBERKELEY, Calif., July 30, 2018 (GLOBE NEWSWIRE) ...

BeyondSpring to Present at the Deutsche Bank 43rd Annual Health Care Conference

NEW YORK, May 07, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ:BYSI), a global, clinical-stage ...

Basilea launching antifungal CRESEMBA(r) (isavuconazole) in the United Kingdom

BASEL, Switzerland, March 3, 2016 (GLOBE NEWSWIRE) -- Basilea Pharmaceutica Ltd. (SIX: BSLN) hosts ...